Reduction effect of oral pravastatin on the acute phase response to intravenous zoledronic acid: protocol for a real-world prospective, placebo-controlled trial

INTRODUCTION: Zoledronic acid (ZA) has been used as a first-line treatment in patients with osteoporosis (OP) who receive an annual injection of 5 mg. However, side effects of bone pain and fever, known as the acute phase response (APR), have often been observed after clinical usage. A meta-analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qi, Han, Gengyu, Li, Runting, Fan, Dongwei, Du, Guohong, Zhang, Min, Tao, Liyuan, Li, Haiyan, Liu, Dongyang, Song, Chunli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280907/
https://www.ncbi.nlm.nih.gov/pubmed/35831045
http://dx.doi.org/10.1136/bmjopen-2021-060703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280907/
https://www.ncbi.nlm.nih.gov/pubmed/35831045
http://dx.doi.org/10.1136/bmjopen-2021-060703

Ejemplares similares